首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

1461478

全球主動脈瘤市場規模、佔有率、成長分析、按類型、按治療方法、按產品、按最終用途 - 行業預測，2024-2031 年

Global Aortic Aneurysm Market Size, Share, Growth Analysis, By Type(Thoracic Aortic Aneurysm, and Abdominal Aortic Aneurysm ), By Treatment(Open Surgical Repair, Endovascular Aneurysm Repair ), By Product, By End-use - Industry Forecast 2024-2031

出版日期: 2024年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球主動脈瘤市場規模估值為47億美元，從2023年的51億美元成長到2031年的98.1億美元，預測期間（2024-2031）年複合成長率為8.52%。

該市場的成長主要是由於動脈粥狀硬化和人口老化的日益普遍、有利的醫療保健報銷法規以及對微創醫療程序的需求迅速成長所推動。由於心血管疾病、久坐的生活方式和不健康的飲食習慣的增加，主動脈瘤（AA）的全球盛行率正在上升。據美國衛生與公眾服務部稱，這一趨勢因美國老年人口數量不斷增加而進一步加速，老年人口佔總人口的16%以上，到2040年將達到8080萬，到2060年將達到9470萬.這是預料之中的。因此，由於人口迅速老化，預計未來 5 年內 AA 修復治療將會增加。 65歲及以上的老年人由於主動脈壁的老齡化相關性減弱，更容易患主動脈瘤，並且與其他心血管疾病相關的風險也會增加。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Medtronic PLC
Cook Medical
Terumo Corporation
Lombard Medical（MicroPort Scientific Corporation）
WL Gore & Associates, Inc.
Endologix, Inc.
Cardinal Health, Inc.
CR Bard, Inc.（Becton, Dickinson and Company）
Bolton Medical（Vascutek Ltd.）
JOTEC GmbH
Merit Medical Systems, Inc.
MicroPort Scientific Corporation
CryoLife, Inc.
Lemaitre Vascular, Inc.
Endospan Ltd.
Japan Lifeline Co., Ltd.
Getinge AB
Altura Medical（Cardinal Health）
BiFlow Medical Ltd.
LeMaitre Vascular, Inc.

簡介目錄

Product Code: SQMIG35A2601

Global Aortic Aneurysm Market size was valued at USD 4.7 billion in 2022 and is poised to grow from 5.10 billion in 2023 to 9.81 billion in 2031, at a CAGR 8.52% during the forecast period (2024-2031).

The market's growth is primarily fueled by the increasing prevalence of atherosclerosis and the expanding aging population, alongside favorable health reimbursement regulations and a surge in demand for minimally invasive medical procedures. Global prevalence of aortic aneurysms (AA) is on the rise due to escalating cases of cardiovascular diseases, sedentary lifestyles, and unhealthy dietary habits. The growing elderly population, comprising over 16% of the total population in the United States according to the U.S. Ministry of Health and Human Services, is further amplifying this trend, expected to reach 80.8 million by 2040 and 94.7 million by 2060. Consequently, there is an anticipated increase in AA repair treatments over the next five years, attributed to the rapidly aging demographic. Individuals aged over 65 are more susceptible to aortic aneurysms due to age-related weakening of the aorta's walls, with heightened risk associated with other cardiovascular conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the global aortic aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Aneurysm Market Segmental Analysis

The global aortic aneurysm market is segmented on the basis of type, treatment, product, end-use, and region. Based on type, the market is segmented into Thoracic Aortic Aneurysm (TAA), and Abdominal Aortic Aneurysm (AAA). Based on treatment, the market is segmented into Open Surgical Repair (OSR), and Endovascular Aneurysm Repair (EVAR). Based on Product the market is segmented into Stent Grafts, and Catheters. Based on End-use the market is segmented into Hospitals, Ambulatory Surgery Centers, Clinics. Based on region the global Aortic Aneurysm Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Aortic Aneurysm Market

The rising incidence of aortic aneurysms, particularly in aging populations, is a significant driver for market growth. Factors such as hypertension, smoking, and atherosclerosis contribute to the increasing prevalence of aortic aneurysms, necessitating effective diagnosis and treatment options.

Restraints in the Global Aortic Aneurysm Market

One major obstacle within the aortic aneurysm market lies in the insufficient awareness regarding the condition among both the general populace and healthcare providers. This deficiency can lead to underdiagnosis, treatment delays, and suboptimal patient outcomes, thereby impeding the market's expansion.

Market Trends of the Global Aortic Aneurysm Market

Digital transformation has become widespread across various industries as companies adopt technologies such as artificial intelligence, machine learning, big data analytics, cloud computing, and the Internet of Things (IoT) to streamline operations, improve customer satisfaction, and secure a competitive advantage.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Aortic Aneurysm Market by Type

Market Overview
Thoracic Aortic Aneurysm (TAA)
and Abdominal Aortic Aneurysm (AAA)

Global Aortic Aneurysm Market by Treatment

Market Overview
Open Surgical Repair (OSR)
Endovascular Aneurysm Repair (EVAR)

Global Aortic Aneurysm Market by Product

Market Overview
Stent Grafts
and Catheters

Global Aortic Aneurysm Market by End-use

Market Overview
Hospitals
Ambulatory Surgery Centers
Clinics

Global Aortic Aneurysm Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical (MicroPort Scientific Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard, Inc. (Becton, Dickinson and Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bolton Medical (Vascutek Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JOTEC GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lemaitre Vascular, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endospan Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Lifeline Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altura Medical (Cardinal Health)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiFlow Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LeMaitre Vascular, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments